Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00238_DB01076> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00238_DB01076 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00238_DB01076 label "DDI between Nevirapine and Atorvastatin - Nevirapine, a strong CYP3A4 inducer, may decrease the serum concentration of atorvastatin by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if nevirapine is initiated, discontinued or dose changed. [drugbank_resource:DB00238_DB01076]" assertion.
- drugbank_resource:DB00238_DB01076 identifier "drugbank_resource:DB00238_DB01076" assertion.
- drugbank_resource:DB00238_DB01076 title "DDI between Nevirapine and Atorvastatin - Nevirapine, a strong CYP3A4 inducer, may decrease the serum concentration of atorvastatin by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if nevirapine is initiated, discontinued or dose changed." assertion.